Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. The company was founded in 1987 on the discovery of a hormone, amylin, produced by the same beta cells of the pancreas that make insulin. Since then, Amylin has built a strong foundation on research and development. Amylin's scientists are primarily focused on investigating the potential utility of new peptide hormone candidates. The company has amassed significant research and clinical expertise in metabolic medicine including the areas of diabetes, obesity and cardiovascular disease. The Amylin team is comprised of highly motivated and committed scientists and business professionals who strive to make advancements in the world of medicine and improve the communities in which we live. We value talent, commitment, passion, and diversity in our employees and promote a friendly culture that embraces creativity and different perspectives.  We encourage employee development and recognize accomplishments. 

Career Opportunities
View Amylin Job Opportunities click here